Yatharth Hospital & Trauma Care Services Ltd (NSE: YATHARTH, BSE: 543950) is a Noida, Uttar Pradesh-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹9,559 Cr, it ranks #600 by market cap among the 6,137 Indian listed companies on FinBizNet, and #11 of 42 in Hospitals and Healthcare Centers. At ₹931.80 (as of 25 Oct 2026), the share price is 21.3% below its 52-week high of ₹1,184.00 and 73.1% above its 52-week low of ₹538.25. The share price is up 14.2% over one year and up 11.1% over three months.
| Current Price | ₹931.80 |
|---|---|
| Market Cap | ₹9,559 Cr |
| NSE Symbol | YATHARTH |
| BSE Code | 543950 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 53.5 |
| Return on Equity | 9.89% |
| Return on Assets | 6.39% |
| 52-Week Range | ₹538.25 – ₹1,184.00 |
| 1-Year Price Change | +14.2% |
| 3-Month Price Change | +11.1% |
| Beta (1Y) | 0.41 |
| Dividend Yield | 0.10% |
| Headquarters | Noida, Uttar Pradesh |
| Website | www.yatharthhospitals.com |
| Revenue | ₹393 Cr |
|---|---|
| Net Profit | ₹45 Cr |
| Net Margin | 11.6% |
| EPS (Basic) | ₹4.88 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney transplant, IVF and fertility, emergency medicine, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, nutrition and health, interventional spine and pain medicine, neurology, neurosurgery, and cardiovascular and thoracic surgery. In addition, the company sells medicines and canteen food. The company was
1. Medical and Healthcare Services-This segment offers hospital services. 2. NA-NA 3. NA-NA 4. NA-NA
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Yatharth Hospital & Trauma Care Services Ltd | ₹9,559 Cr | 53.5 | 9.89% | ₹393 Cr | +14.2% |
Listed by market capitalisation. Ratios are shown for context only.
Yatharth Hospital & Trauma Care Services Ltd is trading at ₹931.80, with a market capitalisation of ₹9,559 Cr.
Yatharth Hospital & Trauma Care Services Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Yatharth Hospital & Trauma Care Services Ltd has a P/E of 53.5 and a return on equity of 9.89%.
Yatharth Hospital & Trauma Care Services Ltd is listed on the NSE under the symbol YATHARTH and on the BSE under the scrip code 543950.
Yatharth Hospital & Trauma Care Services Ltd's share price is up 14.2% over one year and up 11.1% over three months. Its 52-week range is ₹538.25 to ₹1,184.00.
In Q1 FY27, Yatharth Hospital & Trauma Care Services Ltd reported revenue of ₹393 Cr and net profit of ₹45 Cr, with basic EPS of ₹4.88 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.